The Child-Turcotte-Pugh (CTP) score is a point-based system that grades liver disease severity into three classes, A through C, with each step corresponding to a measurably worse prognosis. A person classified as CTP Class A has well-compensated cirrhosis and a relatively favorable outlook, while someone in Class C has advanced decompensation and faces substantially higher short-term mortality. Originally designed in the 1960s to predict surgical outcomes, the score has evolved into one of the most widely used tools in hepatology, shaping decisions about transplant timing, drug dosing, and cancer treatment eligibility.
What the Score Actually Measures
The CTP score evaluates five clinical variables, each scored on a scale of 1 to 3 points depending on severity. The total ranges from 5 to 15, and patients are grouped into three classes based on where they fall. Class A covers 5 to 6 points, Class B spans 7 to 9, and Class C includes 10 to 15. The original classification was proposed in 1964 by Child and Turcotte, who used five variables to stratify patients with bleeding varices: bilirubin levels, albumin levels, the presence of ascites, the degree of hepatic encephalopathy, and nutritional status. In 1973, Pugh and colleagues modified the system by swapping out nutritional status for prothrombin time and adjusting the cutoff values for bilirubin and albumin, producing the version still used today.1PubMed Central. The Child-Turcotte Classification: From Gestalt to Sophisticated Statistics and Back
Each of the five parameters captures a different dimension of how well the liver is functioning. Bilirubin reflects the liver’s ability to process and excrete waste. Albumin, a protein made by the liver, signals its synthetic capacity. Prothrombin time measures how well the blood clots, which depends heavily on clotting factors the liver produces. Ascites (fluid buildup in the abdomen) and hepatic encephalopathy (confusion caused by toxins the liver fails to clear) are both clinical signs that the liver can no longer keep up with its workload. The beauty of the system is that it blends laboratory values with bedside findings, giving clinicians a quick snapshot of liver reserve without needing advanced imaging or invasive testing.
How Each Class Translates to Prognosis
The practical significance of CTP class becomes most obvious in surgical settings. A systematic review examining cardiac surgery in cirrhotic patients found that short-term mortality (within 30 days) was roughly 9% for Class A patients, jumped to about 38% for Class B, and reached around 52% for Class C.2PubMed. Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score That steep climb between classes is what makes the score so useful for preoperative risk stratification. A surgeon considering an elective procedure on a Class A patient faces very different odds than one operating on a Class C patient.
In a study of cardiac surgery patients with cirrhosis, a cutoff CTP score above 7 had a sensitivity of 86% and specificity of 92% for predicting mortality, with a negative predictive value of 97%. In plain terms, if your score was 7 or below, the chances of surviving surgery were very high; if it was above 7, the picture changed dramatically.3Clinical Gastroenterology and Hepatology. Predicting outcome after cardiac surgery in patients with cirrhosis: A comparison of Child-Pugh and MELD scores These numbers explain why many surgical teams consider Class C cirrhosis a near-absolute contraindication to elective operations and approach Class B patients with extreme caution.
Why Liver Disease Disrupts So Many Body Systems
To understand why the CTP score captures prognosis so well, it helps to know what cirrhosis actually does to the body. The liver is the primary factory for clotting factors, albumin, and the enzymes that process bilirubin, so when it fails, all five CTP variables deteriorate in tandem. Patients with cirrhosis have impaired production of most factors involved in coagulation and fibrinolysis, combined with altered platelet counts caused by portal hypertension.4PubMed Central. Anticoagulation in cirrhosis: a new paradigm? These coagulation problems are driven by multiple overlapping mechanisms: reduced synthesis of both clotting and inhibitor factors, impaired clearance of activated factors, qualitative and quantitative platelet defects, and increased breakdown of clots.5PubMed Central. Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management
Portal hypertension, a hallmark of advancing cirrhosis, creates its own cascade of problems. As resistance to blood flowing into the liver increases, collateral blood vessels form and arterial vasodilation progresses, eventually leading to the development of esophageal varices and ascites.6PubMed Central. Pathophysiology of portal hypertension Because the CTP score directly captures ascites, encephalopathy, and the lab markers that reflect synthetic failure, it functions as a surprisingly comprehensive proxy for how much damage the liver has sustained and how many downstream systems are affected.
How the CTP Score Compares to the MELD Score
If you’ve spent any time reading about liver disease, you’ve almost certainly encountered the MELD score as well. MELD (Model for End-Stage Liver Disease) uses three lab values: bilirubin, creatinine, and INR (a standardized measure of clotting time). It was adopted in 2002 as the basis for liver transplant organ allocation in the United States, largely because it relies entirely on objective lab data and avoids the subjectivity of grading ascites or encephalopathy at the bedside. So which one is better?
The honest answer is that neither consistently outperforms the other across all clinical scenarios. A large systematic review and meta-analysis pooling data from over a hundred eligible studies found that out of 269 comparisons between the two scores, 44 favored MELD, 16 favored CTP, 99 found no significant difference, and 110 didn’t report statistical significance at all.7PubMed Central. Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies The results varied by clinical context. In patients with acute-on-chronic liver failure, CTP had higher sensitivity but lower specificity than MELD. In ICU patients, MELD had higher sensitivity. In surgical patients, CTP had higher specificity. For most other situations, the two scores performed similarly.
A study looking specifically at patients undergoing TIPS (a procedure that creates a shunt to relieve portal hypertension) found that while MELD was the stronger predictor in a statistical model of overall survival, both scores predicted one-month, three-month, and one-year survival with equal accuracy. The authors concluded there was little reason to replace the well-established CTP score for assessing prognosis in that setting.8PubMed. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt In practice, most hepatologists use both scores, leaning on MELD for transplant listing and on CTP for broader clinical decision-making.
The CTP Score in Drug Dosing
One of the score’s most underappreciated roles is in pharmacology. The liver metabolizes a huge proportion of medications, so when liver function declines, drug levels can build up to toxic concentrations. Regulatory agencies and drug manufacturers use the CTP classification to provide dosing guidance, and this is particularly common in oncology. A review of 39 oncologic small-molecule and cytotoxic drugs found that initial dosing recommendations for patients with liver impairment were based on CTP scores alone for 46% of the drugs examined, and on liver function tests alone for 26%.9PubMed Central. A review of the evidence base for utilizing Child-Pugh criteria for guiding dosing of anticancer drugs in patients with cancer and liver impairment
This means nearly half of the cancer drugs studied relied on CTP class to determine whether a patient should receive a full dose, a reduced dose, or none at all. In practice, many drug labels will state something like “no adjustment needed for Child-Pugh A, reduce dose by 50% for Child-Pugh B, avoid use in Child-Pugh C.” A multidisciplinary expert panel of hepatologists, clinical pharmacologists, and clinical pharmacists recently evaluated drug-selection and dose-adjustment practices across CTP stages, working to harmonize recommendations for patients with cirrhosis.10PubMed Central. Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert Panel If you have cirrhosis and are prescribed a new medication, your CTP class is quite likely influencing the dose you receive, even if nobody explains that to you directly.
Cancer Treatment and Hepatocellular Carcinoma
Liver cancer, particularly hepatocellular carcinoma (HCC), frequently develops in people who already have cirrhosis. This creates a difficult clinical problem: the cancer needs treatment, but the liver may not tolerate aggressive therapy. Most landmark clinical trials for HCC drugs have required participants to be CTP Class A, meaning that the safety and effectiveness of these treatments in patients with worse liver function is less well established.
Real-world data, however, suggests the picture for Class B patients may not be as bleak as the exclusion from trials implies. A study examining treatment patterns in a community oncology setting found that survival outcomes for patients with advanced HCC receiving first-line systemic therapy were similar for CTP Class A and Class B.11PubMed Central. Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting Survival was also longer for patients who had received liver-directed therapy before starting systemic treatment. These findings don’t mean Class B patients can be treated identically to Class A patients, but they do challenge the assumption that systemic therapy is futile once the liver function dips below the best category.
Can CTP Scores Improve Over Time?
One of the most common questions people have after learning their CTP class is whether it can get better. The answer, perhaps surprisingly, is yes, though it depends heavily on the underlying cause. If the driving factor behind cirrhosis is removed or controlled, some patients experience what hepatologists call re-compensation. In a study of patients with hepatitis B-related decompensated cirrhosis who started antiviral therapy, re-compensation occurred in about 57% of the derivation cohort and about 67% of the validation cohort.12PubMed. Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy
Case reports have documented even more dramatic reversals. In a series of patients with chronic hepatitis B who had clinical, biochemical, and histologic evidence of cirrhosis, antiviral treatment with interferon or lamivudine led to remarkable improvements. The mean CTP score dropped from 8 to 5, bilirubin fell from 2.4 to 0.9, prothrombin time shortened from 16.3 to 12.3 seconds, and fibrosis scores decreased dramatically.13Clinical Gastroenterology and Hepatology. Reversibility of cirrhosis in chronic hepatitis B A CTP score going from 8 (Class B) to 5 (Class A) represents a meaningful shift in prognosis and quality of life. Similar improvements can occur when alcohol-related liver disease patients achieve sustained abstinence, or when autoimmune hepatitis responds to immunosuppressive therapy. The key takeaway is that CTP class is not necessarily a one-way street downward.
Quality of Life Beyond Survival Numbers
The CTP score predicts survival, but patients care about more than whether they are alive. They want to know how they’ll feel. Research confirms that health-related quality of life deteriorates as CTP class worsens: physical functioning, energy levels, and overall well-being all decline as patients move from Class A to Class C.14The American Journal of Gastroenterology. Cholestatic liver diseases and health-related quality of life
Interestingly, though, the CTP score itself may not be the strongest predictor of how a patient rates their own quality of life. A study of patients with decompensated cirrhosis found that sleep quality and frailty were more strongly associated with self-reported quality of life than the CTP score, which actually dropped out of the statistical model once those factors were accounted for.15PubMed Central. Health‐Related Quality of Life and Its Contributors According to a Preference‐Based Generic Instrument in Cirrhosis This matters because it suggests that interventions targeting sleep and physical conditioning might improve a patient’s daily experience even when the CTP score itself isn’t changing much. Frailty and sleep disruption are potentially modifiable in ways that lab values sometimes are not.
Predicting Healthcare Costs and Resource Use
Beyond its clinical uses, the CTP score turns out to be a useful predictor of economic outcomes after major procedures. In a study of patients with primary sclerosing cholangitis undergoing liver transplantation, the CTP score was a significantly better predictor than the disease-specific Mayo PSC model for death within four months, prolonged hospital stays, and high resource utilization. When both models were tested head-to-head, the CTP score remained significant after adjusting for the Mayo model, but the reverse was not true.16Liver Transplantation. Predicting Clinical and Economic Outcomes After Liver Transplantation Using the Mayo Primary Sclerosing Cholangitis Model and Child-Pugh Score For transplant centers making resource allocation decisions, this kind of dual predictive power, covering both survival and cost, makes the CTP score a practical planning tool as well as a clinical one.
Using the CTP Score in Children
The CTP score was designed for adults, and children with liver disease present different challenges. Normal lab values vary by age, the causes of pediatric liver disease differ from those in adults, and developmental factors complicate the clinical assessment of encephalopathy. Pediatric hepatology has its own dedicated scoring systems, most prominently the PELD (Pediatric End-Stage Liver Disease) score, which is used for transplant allocation in children under 12.
Despite this, the CTP score still gets used in pediatric settings, and research shows it correlates positively with PELD scores.17Transplantation Proceedings. Comparison of Child-Turcotte-Pugh and Pediatric End-Stage Liver Disease Scoring Systems to Predict Morbidity and Mortality of Children Awaiting Liver Transplantation However, newer tools are showing stronger performance in pediatric populations. A study evaluating children with decompensated chronic liver disease found that a pediatric adaptation of an organ-failure scoring system outperformed both the CTP score and PELD in predicting 28-day mortality, with an area under the curve of 0.977 compared to 0.815 for CTP and 0.741 for PELD.18Journal of Hepatology. Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease For parents navigating a child’s liver disease, the CTP class still provides a rough guide to severity, but pediatric-specific scores may give clinicians more precise information for acute decision-making.
Known Limitations and Proposed Fixes
The CTP score has endured for more than 50 years, which speaks to its usefulness, but it has well-recognized weaknesses. Two of its five components, ascites and encephalopathy, are graded subjectively. One physician might call a patient’s ascites “mild” while another calls it “moderate,” and that single-point difference can shift a patient from one class to another. The boundaries between classes are also somewhat arbitrary: a patient scoring 6 (top of Class A) and one scoring 7 (bottom of Class B) have very similar liver function but land in different risk categories with different treatment implications.
Another limitation is that the score doesn’t account for kidney function, which is a major independent predictor of death in cirrhosis. This is precisely what the MELD score was designed to address by including creatinine. Researchers have tried to bridge this gap by creating a creatinine-modified CTP score, adding serum creatinine as a sixth variable to produce a score ranging from 5 to 19. In one study, this modified score was far better than the standard CTP at predicting moderate and severe hepatic encephalopathy, with an area under the curve of 0.852 compared to just 0.610 for the original score.19PubMed Central. Comparison Between Creatinine-Modified Pugh Score and Child-Pugh Score for Prognostication in Decompensated Cirrhosis Whether this modification will gain wide adoption remains to be seen, but it highlights a clear direction for improvement.
Efforts to automate the score and make it computable from electronic health records are also underway. Researchers have developed algorithms to calculate CTP scores from large healthcare databases, which could enable more consistent population-level tracking and quality improvement efforts.20PubMed Central. Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database Standardizing how the subjective components are recorded and coded would reduce some of the variability that currently limits the score’s reliability across different clinicians and institutions.
When CTP Class Guides Specific Interventions
Beyond general prognosis, CTP class sometimes determines whether a patient qualifies for a specific life-saving procedure. Pre-emptive TIPS placement after acute variceal bleeding is a good example. A study of patients with variceal bleeding found that early TIPS placement was associated with reduced mortality compared to standard drug-plus-endoscopy treatment, but the survival benefit was concentrated among patients with CTP Class B scores of 8 or 9 who had active bleeding. Patients with CTP B7 and active bleeding did not show a clear benefit.21JHEP Reports. CLIF-C AD score predicts survival benefit from pre-emptive TIPS in individuals with Child-Pugh B cirrhosis and acute variceal bleeding The difference between a B7 and a B8, just one point on the CTP scale, could mean the difference between a procedure being recommended or withheld. This kind of granularity within classes underscores that the score isn’t just a blunt sorting tool; fine distinctions within a class can carry real clinical weight.
Some cardiac surgery teams have found, however, that the CTP class and MELD score are not always the strongest predictors of surgical outcomes. One analysis found that preoperative bilirubin level and a cardiac-specific risk score were more closely associated with early and late mortality after heart surgery in cirrhotic patients than either CTP class or MELD.22PubMed Central. Cardiac surgery in patients with liver cirrhosis: risk factors for predicting mortality This is a reminder that no single scoring system captures every relevant variable. When surgery is being planned, the CTP score is one input among several, not the final word.